×

Global Tissue Diagnostics (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer) Market - Trends & Forecast to 2018

Research and Markets logo

Dublin, July 16, 2014 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/28cjbf/tissue) has announced the addition of the "Tissue Diagnostics Market by Technology, Disease, Product, End-Users & Region - Trends & Forecast to 2018" report to their offering.

Tissue diagnostics is used to determine the stage, prognosis, and treatment course of cancer. The rapidly increasing incidence of cancer and the increasing use of tissue diagnostic products for companion diagnostics in personalized medicine will be the two most important growth drivers for this market during the forecast period between 2013 and 2018. Furthermore, as advanced age is considered to be an important risk factor for cancer, the rapidly aging global population will further drive the demand for tissue diagnostic products.

The report provides a granular understanding of the market. It segments the global tissue diagnostics market by technology, disease, product, end user, and geography. Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining are the technology segments of the market included in this report. The IHC technology segment commanded the largest share of the global market and is also poised to grow at the highest CAGR between 2013 and 2018, owing to its increasing use as companion diagnostics in personalized medicine for cancer.

The disease segments included in this report are breast cancer, gastric cancer, lymphoma, prostate cancer, non-small-cell lung cancer (NSCLC), and other diseases segments. The breast cancer disease segment commanded the largest share of the global market, and is also poised to grow at the highest CAGR between 2013 and 2018, due to the sharp increase in the incidences of disease owing to lifestyle changes and environmental factors.

The end-user segments of the tissue diagnostics market included in this report are hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users like reference laboratories. The hospital end-user segment commanded the largest share of the global market, while the research laboratories end-user segment is poised to grow at the highest CAGR between 2013 and 2018.

The geographic segments of the global tissue diagnostics market are the Americas, Europe, BRIC, Japan, and the Rest of the World (RoW). The Americas is further divided into the U.S., Canada, Mexico, Chile, and the Rest of the Americas. The Europe segment is further divided into the regional segments of Germany, France, Italy, Spain, the U.K., and the Rest of Europe. The BRIC segment includes Brazil, Russia, India, and China.


Key Topics Covered:

1 Introduction

2 Executive Summary

3 Premium Insights

4 Market Overview

5 Global Tissue Diagnostics Market, By Technology

6 Global Tissue Diagnostics Market, By Disease

7 Global Tissue Diagnotics Market, By Product

8 Global Tissue Diagnostics Market, By End User

9 Geographic Analysis

10 Competitive Landscape

11 Company Profiles


Companies Mentioned:

  • Abbott Laboratories, Inc.
  • Agilent Technologies
  • Biogenex Laboratories
  • Bio Sb.
  • Cell Signalling Technology, Inc.
  • Danaher Corporation.
  • Life Technologies
  • Roche
  • Sigma Aldrich
  • Thermo Fisher Scientific


For more information visit http://www.researchandmarkets.com/research/28cjbf/tissue

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Medical Devices

Source:Research and Markets